FDA Finalizes Guidance on Child-Resistant Packaging Labeling Statements

Drug Industry Daily
A A
The FDA has issued final guidance on child-resistant packaging (CRP) statements in prescription and non-prescription drug product labeling.

To View This Article:

Login

Subscribe To Drug Industry Daily